データなし
Neurizon Reports Positive Results From Preclinical Study of Amyotrophic Lateral Sclerosis Treatment Candidate; Shares Fall 4%
MT Newswires11/18 12:34
Neurizon's Fast-track Application for Flagship Drug in Europe Received 'Positively'
The Market Herald11/11 07:54
PharmAust Changes Name to Neurizon Therapeutics
MT Newswires10/15 12:42